Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
08/27/2009 | US20090216318 Use of cis-epoxyeicosatrienoic acids and inhibitors of soluble epoxide hydrolase to reduce cardiomyopathy |
08/27/2009 | US20090216005 Small Breast Epithelial Mucin Gene Promoter |
08/27/2009 | US20090216004 Protoporphyrinogen oxidase having activity of imparting resistance against acifluorfen and gene thereof |
08/27/2009 | US20090216003 Stable and selective formation of hoogsteen-type triplexes and duplexes using twisted intercalating nucleic acids (tina) and process for the preparation of tina |
08/27/2009 | US20090215995 isolated nucleic acids encoding B7-related polypeptides, including BSL3, which modulate cells that are important for immune and inflammatory responses, such as T-cells |
08/27/2009 | US20090215994 Novel Centromeric Protein Shugoshin |
08/27/2009 | US20090215987 Peptide amidation process |
08/27/2009 | US20090215880 Composition and Method for IN VIVO and IN VITRO Attenuation of Gene Expression Using Double Stranded RNA |
08/27/2009 | US20090215879 Methods and compositions for adeno-associated virus (aav) with hi loop mutations |
08/27/2009 | US20090215878 Treatment of chronic pain with zinc finger proteins |
08/27/2009 | US20090215875 Methods and kits for expanding hematopoietic stem cells |
08/27/2009 | US20090215874 Aptamers as agonists |
08/27/2009 | US20090215872 Methods for Controlling Stem Cell Differentiation |
08/27/2009 | US20090215871 Simian adenovirus vectors and methods of use |
08/27/2009 | US20090215870 Compositions and methods for targeting of viral vectors |
08/27/2009 | US20090215867 Cancer-Cell-Specific Cell Proliferation Inhibitors |
08/27/2009 | US20090215866 Akt ligands and polynucleotides encoding akt ligands |
08/27/2009 | US20090215865 Nucleic Acid Molecules and Collections Thereof, Their Application and Identification |
08/27/2009 | US20090215864 Oligoribonucleotide inhibitors of NRF2 and methods of use thereof for treatment of cancer |
08/27/2009 | US20090215863 Gene Silencing of Protease Activated Receptor 1(Par1) |
08/27/2009 | US20090215862 Micro rna |
08/27/2009 | US20090215861 Antisense oligonucleotides for treating allergy and neoplastic cell proliferation |
08/27/2009 | US20090215711 Novel compositions and methods in cancer |
08/27/2009 | US20090215698 Lawsonia protein useful as a component in subunit vaccine and methods of making and using thereof |
08/27/2009 | US20090215691 NOGO Receptor Antagonists |
08/27/2009 | US20090215689 Fgf2-binding peptides and uses thereof |
08/27/2009 | US20090215686 Nk1-based polypeptides and related methods |
08/27/2009 | US20090215683 Screening and therapeutic method for nsclc targeting cdca1-kntc2 complex |
08/27/2009 | US20090215680 Inhibitor peptides |
08/27/2009 | US20090215679 Disease-associated proteins |
08/27/2009 | US20090215672 Cys-Rich, Cell Surface Glycoproteins |
08/27/2009 | US20090215667 Utility of phylloplanins as antibiotics, selective fungicides and for enhancing microbial resistance in plants |
08/27/2009 | US20090215663 Savinase variants having an improved wash performance on egg stains |
08/27/2009 | US20090215648 Rapid subcloning using site-specific recombination |
08/27/2009 | US20090215644 producing cells wherein the expression of a target gene is suppressed or a siRNA for the target gene using the element; enables the selective knock-down of a desired gene |
08/27/2009 | US20090215195 Set1 proteins and uses thereof |
08/27/2009 | US20090215179 Transgenically preventing establishment and spread of transgenic algae in natural ecosystems |
08/27/2009 | US20090215178 Methods to enhance the stability and homogeneity of transgene expression in clonal cell lines |
08/27/2009 | US20090215173 PKD Ligands and Polynucleotides Encoding PKD Ligands |
08/27/2009 | US20090215172 Methods and Compositions Related to Cyclic Peptide Synthesis |
08/27/2009 | US20090215170 Plexin family-like polypeptide, DNA encoding the same and uses thereof |
08/27/2009 | US20090215168 Transcriptional control in alicyclobacillus acidocaldarius and associated genes, proteins, and methods |
08/27/2009 | US20090215167 Cationic graft-copolymer for non-viral gene delivery vector |
08/27/2009 | US20090215166 Cationic Polymer for Transporting Nucleic Acids in Cells |
08/27/2009 | US20090215165 High-level expression of recombinant antibody in a mammalian host cell |
08/27/2009 | US20090215164 Recombinant gene of adenovirus vector and p53 gene for treating proliferative diseases |
08/27/2009 | US20090215151 Two-Step Immunization Procedure Against Chlamydia Infection |
08/27/2009 | US20090215149 Membrane proteins; recombinant vectors, cells |
08/27/2009 | US20090215147 Use of Mutant Herpes Simplex Virus-2 for Cancer Therapy |
08/27/2009 | US20090215138 Modified yeast consuming l-arabinose |
08/27/2009 | US20090215135 Novel Gene STS 22 |
08/27/2009 | US20090215132 Novel amide hydrolase gene |
08/27/2009 | US20090215126 Nucleic acid-free thermostable enzymes and methods of production thereof |
08/27/2009 | US20090215120 The Use of Protein S Fusion for Protein Solubilization |
08/27/2009 | US20090215118 D-aminoacylase |
08/27/2009 | US20090215117 Site specific incorporation of keto amino acids into proteins |
08/27/2009 | US20090215116 Identification of a beta-1,3-N-acetylgalactosaminyltransferase (CGTE) from campylobacter jejuni LIO87 |
08/27/2009 | US20090215115 Sialyltransferases comprising conserved sequence motifs |
08/27/2009 | US20090215092 Antibodies for Anthrax |
08/27/2009 | US20090215089 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
08/27/2009 | US20090215076 Methods and substances for the diagnosis and therapy of sepsis and sepsis-like systemic infections |
08/27/2009 | US20090215068 Thermostable proteinases from thermophilic bacteria |
08/27/2009 | US20090215065 Diagnosis and treatment of Hereditary Spastic Paraplegia |
08/27/2009 | US20090215061 Methods and compositions for vitamin k epoxide reductase |
08/27/2009 | US20090215056 Assay for Methylation in the GST-PI Gene |
08/27/2009 | US20090215051 Novel Assay |
08/27/2009 | US20090215048 Method of in-silico improvement of organisms using the flux sum of metabolites |
08/27/2009 | US20090215046 Novel nucleotide and amino acid sequences, and assays methods of use thereof for diagnosis of colon cancer |
08/27/2009 | US20090215045 identifying a human subject having increased or decreased sensitivity to warfarin, by detecting the presence of a single nucleotide polymorphism in the vitamin K epoxide reductase (VKOR) gene |
08/27/2009 | US20090215042 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis |
08/27/2009 | US20090215031 Mutants of mycobacteria and process thereof |
08/27/2009 | US20090215028 Methods and Compositions for Determining Anti-HIV Drug Susceptibility and Replication Capacity of HIV |
08/27/2009 | US20090214751 Soybean Cultivar 7429331 |
08/27/2009 | US20090214750 Soybean Cultivar 7925118 |
08/27/2009 | US20090214749 Soybean Cultivar 7821295 |
08/27/2009 | US20090214748 Soybean Cultivar 7811336 |
08/27/2009 | US20090214747 Soybean Cultivar S070150 |
08/27/2009 | US20090214746 Soybean Cultivar 6214260 |
08/27/2009 | US20090214745 Soybean Cultivar S070152 |
08/27/2009 | US20090214744 Methods for increasing stearate content in soybean oil |
08/27/2009 | US20090214706 Polypeptide |
08/27/2009 | US20090214703 Transgenic Plant Expressing Maltogenic Alpha-Amylase |
08/27/2009 | US20090214653 Bone morphogenetic protein 4 and osteogenic devices and pharmaceutical products containing thereof |
08/27/2009 | US20090214639 Omp p6 vaccine for treating and preventing chlamydia infection |
08/27/2009 | US20090214635 Identification of a conserved region of plasmodium falciparum msp3 targeted by biologically active antibodies |
08/27/2009 | US20090214632 Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions |
08/27/2009 | US20090214629 Gene transfer method |
08/27/2009 | US20090214595 Means for Obtaining Avirulent Leishmania Promastigotes, Promastigotes Obtained, and the Applications Thereof |
08/27/2009 | US20090214589 Recombinant lentiviral vector for expression of a flaviviridae protein and applications thereof as a vaccine |
08/27/2009 | US20090214588 Vaccines against aids comprising cmv/r-nucleic acid constructs |
08/27/2009 | US20090214579 Promoter for introducing a gene into a lymphocyte or blood cell and application thereof |
08/27/2009 | US20090214578 Immunostimulatory Single-Stranded Ribonucleic Acid with Phosphodiester Backbone |
08/27/2009 | US20090214577 Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof |
08/27/2009 | US20090214575 Annexin II and uses thereof |
08/27/2009 | US20090214574 Anti-cd16 binding molecules |
08/27/2009 | US20090214570 Methods and compositions for immunizing against chlamydia infection |
08/27/2009 | US20090214566 Protective anti-glucan antibodies with preference for beta-1,3- glucans |
08/27/2009 | US20090214564 Anti-ephrinb2 antibodies and methods using same |
08/27/2009 | US20090214560 Binding molecules to the human ox40 receptor |
08/27/2009 | US20090214559 Therapeutic Human Anti-IL-1R1 Monoclonal Antibody |